MedPath

YALE UNIVERSITY

YALE UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1701-10-09
Employees
10K
Market Cap
-
Website
http://www.yale.edu

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment

Phase 2
Completed
Conditions
Binge-Eating Disorder
Obesity
Interventions
Behavioral: Cognitive-Behavioral Therapy (CBT)
Drug: NB Medication (on-going from acute treatment)
First Posted Date
2017-02-24
Last Posted Date
2024-02-01
Lead Sponsor
Yale University
Target Recruit Count
31
Registration Number
NCT03063606
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

Self- and Family-management Intervention in HIV+ Chinese Women

Not Applicable
Completed
Conditions
Hiv
Interventions
Behavioral: self- and family-management intervention sessions
First Posted Date
2017-02-10
Last Posted Date
2017-02-10
Lead Sponsor
Yale University
Target Recruit Count
82
Registration Number
NCT03049332
Locations
🇨🇳

Beijing Ditan Hospital, Beijing, China

🇨🇳

Shanghai Public Health Clinical Center, Shanghai, China

Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82

Early Phase 1
Completed
Conditions
Sarcoidosis
Interventions
Drug: Fluorodeoxyglucose
Drug: Rubidium
Diagnostic Test: FDG-PET/CT with Rb82 Myocardial Perfusion Imaging
First Posted Date
2017-02-09
Last Posted Date
2019-08-26
Lead Sponsor
Yale University
Target Recruit Count
15
Registration Number
NCT03048097
Locations
🇺🇸

Yale New Haven Hospital, New Haven, Connecticut, United States

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Maintenance Therapy

Phase 2
Completed
Conditions
Binge-Eating Disorder
Obesity
Interventions
First Posted Date
2017-02-08
Last Posted Date
2024-02-02
Lead Sponsor
Yale University
Target Recruit Count
68
Registration Number
NCT03047005
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

Community Partnership for Healthy Sleep

Completed
Conditions
Pediatric Sleep
First Posted Date
2017-02-08
Last Posted Date
2019-07-05
Lead Sponsor
Yale University
Target Recruit Count
83
Registration Number
NCT03045874
Locations
🇺🇸

Yale New Haven Hospital, New Haven, Connecticut, United States

Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment

Phase 2
Completed
Conditions
Binge-eating Disorder
Obesity
Interventions
Drug: NB medication (Naltrexone Bupropion combination)
Behavioral: Behavioral Weight Loss (BWL) counseling
Other: Placebo
First Posted Date
2017-02-07
Last Posted Date
2023-03-08
Lead Sponsor
Yale University
Target Recruit Count
136
Registration Number
NCT03045341
Locations
🇺🇸

Yale School of Medicine, New Haven, Connecticut, United States

Pivotal Response Treatment (PRT) Telemedicine

Not Applicable
Completed
Conditions
Autism Spectrum Disorder
Interventions
Behavioral: Pivotal Response Treatment
First Posted Date
2017-02-07
Last Posted Date
2020-06-26
Lead Sponsor
Yale University
Target Recruit Count
7
Registration Number
NCT03045263
Locations
🇺🇸

Yale Child Study Center, New Haven, Connecticut, United States

Aggressive Incidents in Medical Settings Study

Completed
Conditions
Aggression
First Posted Date
2017-02-02
Last Posted Date
2020-03-06
Lead Sponsor
Yale University
Target Recruit Count
137
Registration Number
NCT03041272
Locations
🇺🇸

Yale New Haven Hospital Primary Care Center, New Haven, Connecticut, United States

🇺🇸

Middlesex Hospital, Middletown, Connecticut, United States

🇺🇸

Yale New Haven Hospital- St. Raphael, New Haven, Connecticut, United States

A New Wizard for Insulin Sensitivity Estimation From SAP: a Randomized Controlled Trial in Adolescents With T1D

Not Applicable
Withdrawn
Conditions
Diabetes Mellitus
Interventions
Other: individualized insulin sensitivity index (ISind)
First Posted Date
2017-01-27
Last Posted Date
2019-07-11
Lead Sponsor
Yale University
Registration Number
NCT03034759
Locations
🇺🇸

Yale Pediatric Diabetes Research Program, New Haven, Connecticut, United States

Cognitive Therapy to Sustain the Antidepressant Effects of Intravenous Ketamine in Treatment-resistant Depression

Not Applicable
Completed
Conditions
Depressive Disorder, Major
Interventions
Other: Cognitive behavioral therapy (CBT) and medication
Other: Psychoeducation and medication
First Posted Date
2017-01-23
Last Posted Date
2020-02-05
Lead Sponsor
Yale University
Target Recruit Count
28
Registration Number
NCT03027362
Locations
🇺🇸

Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath